However, in the analysis of several breast cancer datasets, previous reports showed differences of subtype-specific mRNA and promoter methylation in IDO1, with TNBC/basal subtypes exhibiting low methylation/higher expression phenotype and ER+/luminal subtypes demonstrating high methylation/lower expression phenotype (15). This evidence concerns the gene IDO1 and breast carcinoma.